US Patent Issued to SeLux Diagnostics on May 27 for "Systems and methods for performing antimicrobial susceptibility testing" (Massachusetts Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,632, issued on May 27, was assigned to SeLux Diagnostics Inc. (Charlestown, Mass.).

"Systems and methods for performing antimicrobial susceptibility testing" was invented by Kelly Flentie (Charlestown, Mass.) and Eric Stern (Charlestown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Phenotypic antimicrobial susceptibility testing (AST), the gold-standard diagnostic that indicates whether an antimicrobial will be clinically effective, often suffer the slowest times-to-result for the most resistant pathogens. Here we introduce novel assays to be performed in parallel with standard AST assays that provide additional resistance information and en...